Selected article for: "target type and tumor tumor"
Author: Pruitt, Hawley C.; Devine, Daniel J.; Samant, Rajeev S.
Title: Roles of N-Myc and STAT interactor in cancer: From initiation to dissemination
  • Document date: 2016_3_11
    • ID: k3vjqumq_36
    Snippet: Non-transformed cells in the tumor microenvironment directly influence tumor progression. Therefore, the role of NMI in the tumor microenvironment and host cells may impact the course of disease progression. Studies using genetic model systems will provide critical insights into these roles of NMI. Lastly, studies of NMI regulation will allow a unique opportunity for the development of therapeutic strategies that target NMI which may differ depen.....
    Document: Non-transformed cells in the tumor microenvironment directly influence tumor progression. Therefore, the role of NMI in the tumor microenvironment and host cells may impact the course of disease progression. Studies using genetic model systems will provide critical insights into these roles of NMI. Lastly, studies of NMI regulation will allow a unique opportunity for the development of therapeutic strategies that target NMI which may differ depending on the cancer type.

    Search related documents:
    Co phrase search for related documents
    • cancer type and NMI role: 1
    • cancer type and therapeutic strategy: 1, 2, 3
    • cancer type and tumor microenvironment: 1, 2, 3, 4, 5, 6, 7, 8
    • cancer type and tumor progression: 1, 2, 3
    • critical insight and unique opportunity: 1
    • disease progression and genetic model: 1, 2, 3, 4, 5
    • disease progression and genetic model system: 1
    • disease progression and NMI role: 1
    • disease progression and therapeutic strategy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
    • disease progression and tumor microenvironment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • disease progression and tumor progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41
    • disease progression and unique opportunity: 1
    • disease progression course and tumor progression: 1